MedPath

Biliary or Digestive Protection by Room Air Interposition for Thermal Ablation of Central Hepatic Tumors

Completed
Conditions
Carcinoma, Hepatocellular (RENI)
Ablation Techniques
Radiofrequency Ablation
Neoplasm Metastasis
Microwaves
Radiology, Interventional
Liver Neoplasm
Interventions
Procedure: Thermal Ablation
Registration Number
NCT05495529
Lead Sponsor
Centre Hospitalier Universitaire de Nice
Brief Summary

This study aims to analyse retrospectively the feasibility, the safety, and the efficiency, of biliary or digestive protection with room air interposition for thermal ablation of central liver tumors with high iatrogenic risk.

Thermal ablation is a mini-invasive and curative treatement of liver tumors. However, it requires to be carefull about surrunding organs, such as digestive structures or central biliary tree, which can be injured if not insulated.

The technique of gas interposition to protect adjacent gut is already known and validated with carbonic gas. Nevertheless, resorption of this gas is very fast, making its use tricky to keep a correct insulation during the whole thermal ablation process.

Room air interposition is easy to use and can offer a slow resorption speed. Furthermore no datas are available concerning the use of room air whatever the organ protected, and the protection of central biliary tree whatever the gas used.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
61
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
PatientsThermal AblationPatients with single liver tumor traited by thermoablation with high iatrogenic risk, with biliary or digestive protection by ambiant air interposition
Primary Outcome Measures
NameTimeMethod
Feasability1 day

Technical succes of the procedure = feasibility of insulation with room air

Efficacity2 months

Response in imaging (MRI or CT) for the tumor treated with thermal ablation

Clinical success2 months

Overall survival

Security2 months

Complications (intraoperative clinical or radiological event/abnormality, biological perturbation, clinical event in hospitalization report, imaging request), classified according to SIR (Society of Interventional Radiology) classification in two classes: minor (no additional therapy needed) and major (specific therapy needed) complications.

Secondary Outcome Measures
NameTimeMethod
Local tumorous recurrence free survival2 months

Local tumorous recurrence free survival analysis

Progression free survival2 months

Local or distant recurrence free survival analysis

Local and distant recurrence2 months

1. Local recurrence: defined by MRI or CT recurrence within 10 mm from thermal ablation area

2. Distant recurrence:

I. Hepatic: defined by MRI or CT intra-hepatic recurrence which is not defined as local recurrence II. Extrahepatic: defined by MRI or CT extra-hepatic recurrence

Trial Locations

Locations (1)

CHU de Nice

🇫🇷

Nice, France

© Copyright 2025. All Rights Reserved by MedPath